Company Midocrin Srl with Fiscal Code 16730893
recorded a turnover of 2024 of
38.822,
with a net profit of
25.878
and having an average number of employees of
1.
The company operates in the field of Activităţi de contabilitate şi audit financiar; consultanţă în domeniul fiscal having the NACE code 6920.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Midocrin Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
0
7.771
11.723
13.603
12.159
13.090
20.506
22.790
37.128
38.822
Total Income - EUR
0
7.771
11.733
13.741
12.159
13.090
20.506
24.753
37.128
38.822
Total Expenses - EUR
109
1.473
1.737
2.089
2.367
3.077
2.319
3.265
10.461
12.555
Gross Profit/Loss - EUR
-109
6.299
9.995
11.652
9.792
10.013
18.187
21.488
26.668
26.266
Net Profit/Loss - EUR
-109
6.066
9.643
11.240
9.427
9.620
17.584
20.804
26.296
25.878
Employees
0
0
0
0
0
0
0
1
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 5.1%, from 37.128 euro in the year 2023, to 38.822 euro in 2024.
The Net Profit decreased by -271 euro, from 26.296 euro in 2023, to 25.878 in the last year.
Check the financial reports for the company - Midocrin Srl
Financial Rating - MIDOCRIN SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Midocrin Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Midocrin Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Midocrin Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
34.245 euro in 2024 which includes Inventories of
0 euro, Receivables of
2.963 euro and cash availability of
9.168 euro.
The company's Equity was valued at
25.926 euro, while total Liabilities amounted to
8.472 euro.
Equity decreased by -271 euro, from 26.344 euro in 2023, to 25.926 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Midocrin Srl